Clinical Trials
- Liver
A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH (VOYAGE)
- Ages18 years - 75 years
- GenderBoth
- Date07/19/2021
- Hepatitis
An Observational Study of Patients Undergoing Therapy for Chronic Hepatitis B (HBV) Infection
- Ages18 years and older
- GenderBoth
- Date01/31/2019
- Liver
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) (MIRNA)
- Ages18 years - 75 years
- GenderBoth
- Date01/08/2021
- Hepatitis
Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a (D-LIVR)
- Ages18 years and older
- GenderBoth
- Date11/01/2019
- Liver
Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Non-alcoholic Steatohepatitis (NASH) and Stage 3 or Stage 4 Liver Fibrosis
- Ages18 years and older
- GenderBoth
- Date03/06/2020